Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

Model and body activist Tess Holliday clapped back at a critic who told her to take Ozempic for weight loss and they wouldn’t ...

From a celebrity-spruiked success to a relic of diet culture. How a changing world of nutrition led to Weight Watchers' bankruptcy.

Is filler over? The era of the ‘quiet’ facelift is definitely in - LET’S UNPACK THAT: Stealthy, subtle facelifts are on the ...

Novo Nordisk A/S Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related ...

Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.

The first head-to-head trial shows Mounjaro helps people lose more weight than its rival Wegovy as scientists confirm why it ...

A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

Steve Christo-Corbis/Getty Images Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in ...